`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`CELLTRION, INC.,
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`——————————
`
`Case IPR2022-00258
`U.S. Patent No. 9,254,338 B2
`
`PATENT OWNER’S REGENERON PHARMACEUTICALS, INC.’S
`POWER OF ATTORNEY
`FOR UNITED STATES PATENT NO. 9,254,338 B2
`
`-i-
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Regeneron Pharmaceuticals, Inc. hereby
`
`appoints the Practitioners associated with Arnold and Porter Kaye Scholer LLP
`
`(Customer Number 180441), including the following lead and backup counsel as its
`
`attorneys to transact all business in the United States Patent & Trademark Office
`
`Associated with the inter partes Review No. IPR2022-00258.
`
`Lead Counsel
`Deborah E. Fishman (Reg. No.
`48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`Back-Up Counsel
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`David.Caine@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines (pro hac vice to be
`applied for)
`Jeremy Cobb (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Facsimile: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
`Daniel Reisner (pro hac vice to be
`applied for)
`Matthew M. Wilk (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`-ii-
`
`
`
`250 West 55th Street
`New York, New York 10019-9710
`Telephone: 212.836.8000
`Facsimile: 212.836.8689
`Daniel.Reisner@arnoldporter.com
`Matthew.Wilk@arnoldporter.com
`
`-iii-
`
`
`
`Theindividual signing below has authority to execute this documenton behalf
`
`of Patent Owner Regeneron Pharmaceuticals, Inc.
`
`by:FannOrem'
`
`For Patent Owner Regejéron Pharmaceuticals, Inc.
`
`Name: Frank R. Cottingham, Ph.D., J.D.
`
`Title: Executive Director & Assistant General Counsel, Patents
`for Regeneron Pharmaceuticals, Inc.
`
`Dated: February 1, 2022
`
`-iy-
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned certifies that a copy of the foregoing PATENT OWNER’S
`
`POWER OF ATTORNEY was served on February 1, 2022, to the following Counsel
`
`for Petitioner via e-mail:
`
`Lora M. Green (Reg. No. 43,541)
`lgreen@wsgr.com
`Yahn-Lin Chu (Reg. No. 75,946)
`ychu@wsgr.com
`Robert Cerwinski (to be admitted pro hac vice)
`rcerwinski@geminilaw.com
`Aviv Zalcenstein (to be admitted pro hac vice)
`azalcenstein@geminilaw.com
`Brigid Morris (to be admitted pro hac vice)
`bmorris@geminilaw.com
`Wilson Sonsini Goodrich & Rosati
`1700 K Street NW 5th Floor
`Washington DC 20006
`Telephone: (202) 791-8012
`Facsimile: (202) 973-8899
`
`Attorneys for Petitioner Celltrion, Inc.
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`-v-
`
`